Answers are grounded in this paper and cite their sources.
Randomized trial evaluates initial intravenous streptokinase versus heparin before intracoronary streptokinase in acute myocardial infarction, highlighting early reperfusion strategies.
Research Articles| April 21 2009 Intracoronary Streptokinase, OK!... Intravenous Streptokinase, First?: Heparin or Intravenous Streptokinase in Acute Infarction: Preliminary Results of a Prospective Randomized Trial with Angiographic Evaluation in 44 Patients Subject Area: Cardiovascular System , Hematology , Pathology and Cell Biology A. Cribier; A. Cribier Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar J. Berland; J. Berland Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar N. Saoudi; N. Saoudi Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar M. Redonnet; M. Redonnet Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar N. Moore; N. Moore Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar B. Letac B. Letac Cardiological Intensive Care and Cardiovascular Hemodynamic Investigation Units, Teaching Hospital Center, Charles Nicolle Hospital, Rouen, France Search for other works by this author on: This Site PubMed Google Scholar Pathophysiology of Haemostasis and Thrombosis (1986) 16 (Suppl. 3): 122–129. https://doi.org/10.1159/000215377 Article history Published Online: April 21 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation A. Cribier, J. Berland, N. Saoudi, M. Redonnet, N. Moore, B. Letac; Intracoronary Streptokinase, OK!... Intravenous Streptokinase, First?: Heparin or Intravenous Streptokinase in Acute Infarction: Preliminary Results of a Prospective Randomized Trial with Angiographic Evaluation in 44 Patients. Pathophysiology of Haemostasis and Thrombosis 1 March 1986; 16 (Suppl. 3): 122–129. https://doi.org/10.1159/000215377 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsPathophysiology of Haemostasis and Thrombosis Search Advanced Search Article PDF first page preview Close Modal Keywords: Acute myocardial infarction, Intracoronary streptokinase, Intracoronary sterptokinase This content is only available via PDF. 1986Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Cribier et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: